Genome-wide search for susceptibility genes to type 2 diabetes in West Africans: Potential role of C-peptide

Diabetes Research and Clinical Practice

Volumn 78, Issue 3, 2007, Pages

  Chen, Guanjie ^a   Adeyemo, Adebowale ^a   Zhou, Jie ^a   Chen, Yuanxiu ^a   Huang, Hanxia ^a   Doumatey, Ayo ^a   Lashley, Kerrie ^a   Agyenim Boateng, Kofi ^b   Eghan Jr , Benjamin A ^b   Acheampong, Joseph ^b   Fasanmade, Olufemi ^c   Johnson, Thomas ^c   Okafor, Godfrey ^d   Oli, Johnnie ^d   Amoah, Albert ^e   Rotimi, Charles ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^c UNIVERSITY OF LAGOS   (Nigeria)

^d UNIVERSITY OF NIGERIA   (Nigeria)

^e UNIVERSITY OF GHANA   (Ghana)

Author keywords

C peptide; Genome scan; Type 2 diabetes; West Africa

Indexed keywords

C PEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AFRICA; ARTICLE; CHROMOSOME 10Q; CHROMOSOME 15Q; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE REPEAT; QUANTITATIVE TRAIT LOCUS;

AGED; BODY MASS INDEX; C-PEPTIDE; CHROMOSOME MAPPING; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GHANA; HUMANS; MALE; MIDDLE AGED; NIGERIA; REPETITIVE SEQUENCES, NUCLEIC ACID; SIBLINGS;

EID: 35648951175     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.04.010     Document Type: Article

References (29)

1. Johansson B.L., Borg K., Fernqvisit-Forbes E., Odergren T., Remahl S., and Wahren J. C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39 (1996) 687-695
2. Johansson B.L., Linde B., and Wahren J. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35 (1992) 1151-1158
3. Johansson B.L., Sjoberg S., and Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35 (1992) 121-128
4. Forest T., Hunt T., Pfutzner A., Beyer J., and Wahren J. New aspects on biological activity of C-peptide in IDDM patients. Exp. Clin. Endocrinol. Diabetes 106 (1998) 270-276
5. Dufayet D., Raccah D., Jannot M.F., Coste T., Rougerie C., and Vague P. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level. Diabetologia 41 (1998) 1080-1084
6. +-ATPase activity in diabetes mellitus type 1. Clin. Sci. 98 (2000) 281-290
7. +-ATPase activity, metabolic control and neuropathy in IDDM patients. Diabetes Care 19 (1996) 564-568
8. Raccah D., Lamotte-Jannot M.F., Issautier T., and Wague P. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney. Diabetes Metab. 20 (1994) 271-274
9. Rotimi C., Chen G., Adeyemo A., Furbert-Harris P., Guass D., Zhou J., et al. A genome-wide scan for type 2 diabetes susceptibility genes in West Africans. Diabetes 53 (2004) 838-841
10. Rotimi N.C., Dunston G., Berg K., Akinsete O., Amoah A., Owusu S., et al. In search of susceptibility genes for type 2 diabetes in West Africa. The design and results of the first phase of the AADM Study. AEP 11 (2001) 51-58
11. S.A.G.E. Statistical Analysis for Genetic Epidemiology, Release 4.0 (2000), Department of Epidemiology and Biostatistics, Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University, Cleveland, OH
12. O'Chonnell J.R., and Weeks D.E. A program for identifying genotype incompatibilities in linkage analysis. Am. J. Hum. 63 (1998) 259-266
13. Weir B., Genetic Data Analysis II: methods for discrete population genetic data, Sinauer Associates, Sunderland, MA, 1996.
14. Fernandez J.R., Etzel C., Beasley T.M., Shete S., Amos C.I., and Allison D.B. Improving the power of sib pair quantitative trait loci detection by phenotype winsorization. Hum. Hered. 53 (2002) 59-67
15. Allison B.D., Neale C.M., Zannolli R., Schork N., Amos I.C., and Blangero J. Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trail loci-mapping procedure. Am. J. Hum. 65 (1999) 531-544
16. Lander E., and Kruglyak L. Genetic dissection of complex trait: guidelines for interpreting and reporting linkage results. Nat. Genet. 11 (1995) 241-247
17. Johansson B.L., and Pernow J. C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients. Acta Physiol. Scand. 165 1 (1999) 39-44
18. Forst T., Kunt T., Pohlmann T., Goitom K., Engelbach M., Beyer T., et al. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J. Clin. Invest. 101 (1998) 2036-2041
19. Wald H.P., Scherzer P., Rasch R., and Popovtxer M.M. Renal tubular Na-K-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am. J. Physiol. (1993) E96-E101
20. Vague P., Dufayet D., Coste T., Moriscot C., Jannot M.F., and Raccah D. Association of diabetic neuropathy with Na-K-ATPase gene polymorphism. Diabetologia 40 (1997) 506-511
21. Filipsson K., Kvist-Reimer M., and Ahren B. The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function. Diabetes 50 (2001) 1959-1969
22. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. PNAS 100 (2003) 8466-8471
23. Muller Y.L., Bogardus C., Pedersen O., and Baier L. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor r coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes 52 (2003) 895-898
24. Patti M.E. Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology?. Curr. Opin. Clin. Metab. Care 7 4 (2004) 383-390
25. Duggirala R., Blangero J., Almasy L., Dyer T.D., Williams K.L., Leach R.J., et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am. J. Hum. Genet. 64 (1999) 1127-1140
26. Hansen L., Jensen J.N., Ekstrom C.T., Vestergaard H., Hansen T., and Pedersen O. Studies of variability in the PETN gene among Danish Caucasian patients with type 2 diabetes mellitus. Diabetologia 44 (2001) 237-240
27. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
28. Groves C.J., Wiltshire S., Smedley D., Owen K.R., Frayling T.M., Walker M., et al. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes 52 (2003) 1300-1305
29. Karamohamed S., Demissie S., Volcjak J., Liu C., Heard-Costa N., Liu J., et al. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham heart study. Diabetes 52 (2003) 1562-1567